GNVR — Genvor Inc

OTC · Unknown · Unknown · CIK 1792941 ·
Last close
$0.55
Market Cap
$10.79M
52W High
$0.70
52W Low
$0.10
ADV30
367
Next earnings
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
LILIF Argentina Lithium & Energy Corp. $10.77M $0.06
NZERF New Zealand Energy Corp. $11.09M $0.20
MILIF Military Metals Corp. $11.09M $0.14
DFNS T3 Defense Inc. $11.13M $11.01
CCOOF CORE SILVER CORP. $11.16M $0.34

News headlines (Yahoo Finance, 1h cache)

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
2026-07-27 12:00 · Yahoo
Genvor Appoints Donald Kalkofen as Chief Financial Officer
2026-05-21 12:00 · Yahoo
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
2026-04-14 12:00 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
2025-12-09 13:35 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.